Impel NeuroPharma

/Impel NeuroPharma

Follow-on

Impel NeuroPharma

Biopharmaceutical

We are a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, or CNS.

Symbol

IMPL

Last Closing Price
$17.32

Shares
3,000,000

Anticipated Date
September 10, 2021

Underwriters
COWEN AND COMPANY, LLC

This offering is no longer available

To view the prospectus for Impel NeuroPharma, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange